PTSD

Latest News

psychedelics
With MDMA on Hold, What’s Next for Psychedelics?

September 11th 2024

The FDA instead issued a CRL for MDMA-assisted psychotherapy for PTSD, requesting an additional phase 3 trial to examine safety and efficacy. Other psychedelic compounds are proceeding with trials for psychiatric conditions. Learn more here.

Research Roundup
The Anniversary of 9/11 Research Roundup

September 11th 2024

PTSD
MDMA's FDA Pause: An Opportunity to Amplify Approved PTSD Treatments

August 29th 2024

alcohol cannabis
Addressing Alcohol or Cannabis Use in Patients With Anxiety Disorders

August 22nd 2024

PTSD
Exploring the Misuse of PTSD Diagnosis

August 19th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.